Glucose oxidase-engineered cell membrane vesicles co-delivering CRISPR/Cas9 and croconaine dye for traceable synergistic tumor therapy
Smart Materials in Medicine · 2026 · 7 · 514-522
DOI: 10.1016/j.smaim.2026.09.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Smart Materials in Medicine, 2026. Verfasst von Yifan Zhang und 6 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shenzhen Science and Technology Innovation Committee, National Natural Science Foundation of China, Shenzhen University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Shenzhen Science and Technology Innovation Committee
- National Natural Science Foundation of China
- Shenzhen University
- Department of Education of Guangdong Province
- Shenzhen Science and Technology Innovation Program
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Zhang, Y., Dang, Z., Lai, X., Bai, F., Lin, J., Ge, J., & Huang, P. (2026). Glucose oxidase-engineered cell membrane vesicles co-delivering CRISPR/Cas9 and croconaine dye for traceable synergistic tumor therapy. Smart Materials in Medicine, 7, 514-522. https://doi.org/10.1016/j.smaim.2026.09.002
Vancouver
Zhang Y, Dang Z, Lai X, Bai F, Lin J, Ge J, et al. Glucose oxidase-engineered cell membrane vesicles co-delivering CRISPR/Cas9 and croconaine dye for traceable synergistic tumor therapy. Smart Materials in Medicine. 2026;7:514-522. doi:10.1016/j.smaim.2026.09.002
BibTeX
@article{Zhang2026,
author = {Zhang, Yifan and Dang, Zechun and Lai, Xinlan and Bai, Fang and Lin, Jing and Ge, Jianlin and Huang, Peng},
title = {Glucose oxidase-engineered cell membrane vesicles co-delivering CRISPR/Cas9 and croconaine dye for traceable synergistic tumor therapy},
journal = {Smart Materials in Medicine},
year = {2026},
volume = {7},
pages = {514--522},
doi = {10.1016/j.smaim.2026.09.002}
}
EUVIMED